用户48783635432019-04-09 14:29
【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文
艾萨克的猫2018-10-23 23:00
$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ CT ORDER - Confidential treatment order Filed: 2017-03-27 AccNo: 9999999997-17-005069 Size: 11 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Filed: 2017-03-16 AccNo: 0001144204-17-014995 Size: 25 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ UPLOAD [Cover] - SEC-generated letter Filed: 2017-02-07 AccNo: 0000000000-17-004308 Size: 35 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2017-03-13 AccNo: 0001144204-17-014266 Size: 14 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-03-13 AccNo: 0000721371-17-000022 Size: 49 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2017-03-09 AccNo: 0001144204-17-013520 Size: 591 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.01: Completion of Acquisition or Dispositio...
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2017-03-02 AccNo: 0001144204-17-012391 Size: 16 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2017-02-23 AccNo: 0001144204-17-010523 Size: 23 KBItem 8.01: Other Events 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2017-02-16 AccNo: 0001144204-17-009593 Size: 14 KBItem 8.01: Other Events 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2017-02-10 AccNo: 0001144204-17-007377 Size: 19 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...